-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster II

Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

H. Moses Murdock, MD1, Haesook T. Kim, PhD2, Katie Maurer, MD, PhD1, Amar H. Kelkar, MD, MPH, FACP1, Roman M. Shapiro, MD1, Mahasweta Gooptu, MD3, Rizwan Romee, MD1, Corey S. Cutler, MD, MPH1, John Koreth, MD, MBBS, PhD, DPhil1, Jerome Ritz, MD1, Joseph H. Antin, MD1, Vincent T. Ho, MD1*, Sarah Nikiforow, MD, PhD1, Catherine J. Wu, MD1* and Robert J. Soiffer, MD1

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA

Yimei Feng1*, Yijie Wang, PhD2*, Xiaobo Li2*, Da Di, PhD3*, Xiangjun Liu, PhD2* and Xi Zhang, PhD1

1Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqin, China
2Beijing BFR Gene Diagnostics LTD., Beijing, China
3Department of Genetics and Evolution–Anthropology Unit, University of Geneva, Geneva, Switzerland

Anna Eichinger, MD1*, Zofia Szmit, MD, PhD2*, Katharina Kleinschmidt, MD3*, Mouad Abouqateb, MSc, MPH4*, Marc Ansari, MD, PhD5, Peter Bader6, Adriana Balduzzi, MD7,8, Marc Bierings, MD, PhD9, Arnaud Dalissier, BSc4*, Jean-Hugues Dalle, MD, PHD10, Cristina Díaz De Heredia11*, Franca Fagioli, MD, PhD12*, Maura Faraci, MD13*, Jacques-Emmanuel Galimard, PhD4*, Brenda Gibson, MD14*, Peter Lang, MD15*, Oana Mirci-Danicar, MD, PhD16*, Richard Mitchell, MBBS17*, Christina Peters18*, Kanchan Rao19*, Samppa Ryhänen, MD, PhD20*, Martin G. Sauer, MD21, Petr Sedlacek, MD, PhD22*, Jan Styczynski, MD, PhD23*, Selim Corbacioglu, MD3* and Krzysztof Kalwak, MD, PhD24*

1Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU, Munich, Germany
2Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wrocław, Poland
3Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, University Children’s Hospital Regensburg, Regensburg, Germany
4EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
5Department of Pediatrics, Onco-Hematology Unit,, Geneva University Hospital, Geneva, Switzerland
6Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany
7Fondazione IRCCS San Gerardo dei Tintori, Pediatric Hematopoietic Stem Cell Transplant Unit, Monza, Italy
8University of Milano-Bicocca, Monza, Italy
9Princess Maxima Center/ University Hospital for Children (WKZ), Stem cell transplantation, Utrecht, Netherlands
10Hôpital Robert Debre, Pediatric Hematology and Immunology Department, GHU AP-HP Nord – Université Paris Cité, Paris, France
11Department of Pediatric Hematology and Oncology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
12Ospedale Infantile Regina Margherita, Torino, Italy, Torino, Italy
13HSCT Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
14Department of Paediatric Haematology, Royal Hospital for Sick Children, Glasgow, United Kingdom
15Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany
16Bristol Royal Hospital for Children Dept. of Paediatric Haematology/Oncology/BMT, Bristol, United Kingdom
17Kids Cancer Centre, Sydney Children`s Hospital, Randwick, Australia
18Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, St. Anna Children's Hospital, St. Anna Children's Hospital, Vienna, Austria
19Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
20Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
21Hannover Medical University, Hannover, Germany
22University Hospital Motol, Department of Paediatric Haematology and Oncology, Prague, Czech Republic
23University Hospital, Collegium Medicum UMK Pediatric Hematology and Oncology, Bydgoszcz, Poland
24Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland

Hiroaki Shimizu, MD, PhD1, Yuho Najima, MD, PhD2, Shinichi Kako, MD, PhD3, Takayoshi Tachibana, MD, PhD4*, Akihiko Izumi5*, Susumu Tanoue6*, Emiko Sakaida, MD PhD7, Takuya Miyazaki, MD, PhD8*, Katsuhiro Shono, MD, PhD9*, Kota Yoshifuji, MD, PhD10*, Shinichiro Machida11*, Takashi Toya, MD, PhD1*, Noriko Doki1, Satoru Takada, MD12*, Kaoru Hatano13*, Jun Kato, MD, PhD14*, Satoshi Takahashi, MD, PhD15, Jun Taguchi16*, Shingo Yano, MD, PhD17 and Yoshinobu Kanda, MD, PhD3,18*

1Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
2Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, TKY, JPN
3Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
4Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
5Kanagawa Cancer Center, Yokohama, JPN
6Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa-Shi, CHI, Japan
7Department of Hematology, Chiba University Hospital, Chiba City, Japan
8Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan
9Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
10Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-Ku, TKY, JPN
11Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
12Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan
13Jichi Medical University Hospital, Shimotsuke city, Tochigi, JPN
14Division of Hematology, Keio university school of medicine, Shinjuku-Ku, JPN
15The Institute of Medical Science Hospital, Department of Hematology/Oncology, The University of Tokyo, Tokyo, Japan
16Department of Hematology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan
17Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
18Division of Hematology, Jichi Medical University, Tochigi, Japan

Hiroyuki Kubo1*, Osamu Imataki1*, Tetsuya Fukumoto2*, Tomoya Ishida1*, Yukiko Hamasaki Kubo3*, Maki Oku3*, Yui Kawanaka1*, Yu Suezawa1*, Shunsuke Yoshida1*, Shumpei Uchida1*, Makiko Uemura1*, Haruyuki Fujita1* and Norimitsu Kadowaki, M.D., Ph.D.1

1Kagawa University, Kita-County, Japan
2Takamatsu Red Cross Hospital, Takamatsu, Japan
3Kagawa Prefectural Central Hospital, Takamatsu, Japan

Muhammad Umair Mushtaq1,2,3, Amir Kasaeian1,3*, Sibgha Gull Chaudhary, MD1,2,3*, Muhammad Kashif Amin, MD1,2,3*, Naghmeh Khavandgar1,3*, Hediyeh Alemi1,3*, Muhammad Fareed Khalid, MD1,3*, Iqra Anwar, MBBS1,3*, Matthew McGuirk1,2*, Al-Ola Abdallah, MD1,2,3, Anurag K. Singh, MD1,2,3, Mehdi Hamadani, MD3,4, Joseph P. McGuirk, DO1,2,3 and Moazzam Shahzad, MD3,5

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
4Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Yongqiang Zhao*, Yanzhi Song*, Zhihui Li*, Feifei Li*, Dongfang Yang*, Rui Wang*, Fang Fang*, Huiyu Li* and Tong Wu, MD

Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China

Elisa Roldan, MD1,2*, Alba Puyuelo, MD3,4*, Sergi Camarillas, MD5*, Olga Salamero, MD4,6,7*, Ana Perez Gonzalez, MD8,9*, Maria Laura Fox, MD10,11*, Felix Lopez, MD12*, Maria Sola, MD13*, Pere Barba, MD14,15,16, Guillermo Orti, MD, PhD17* and David Valcarcel, MD, PhD6,10

1Autonomous University of Barcelona., Barcelona, Spain
2Sheffield Teaching Hospitals NHS Foundation Trust. Sheffield, United Kingdom, Sheffield, United Kingdom
3Vall D'Hebron University Hospital, Hematology Department, Barcelona, Spain
4Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
5Vall d'Hebron University Hospital, Barcelona, Spain
6Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain
7Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
8Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Barcelona, Spain
9Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, Barcelona, Spain
10Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
11Hematology Department, Vall d'Hebron University Hospital, University Autònoma of Barcelona (UAB), Barcelona, Spain
12Vall D'Hebron Universitary Hospital, Barcelona, Spain
13Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
14Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
15Vall d’Hebron Institute of Oncology (VHIO), Department of Hematology, University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona (UAB), Barcelona, Spain
16Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
17Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Ruijuan Sun1,2*, Yue Lu1,3*, Jian-Ping Zhang1,3*, Jiarui Zhou1,3*, Deyan Liu1,3*, Yanli Zhao1,3*, Zhijie Wei1,3*, Min Xiong1,3*, Xingyu Cao1,3* and Peihua Lu, MD1,3,4

1Beijing Lu Daopei Hospital, Beijing, China
2Hebei Yanda Lu Daopei Hospital, Beijing, China
3Hebei Yanda Lu Daopei Hospital, Langfang, China
4Beijing Lu Daopei Institute of Hematology, Beijing, China

Kristin Rathje1*, Kordelia Barbullushi, MD2*, Nico Gagelmann, MD3*, Anita Badbaran, M. Sc.4*, Johanna Richter4*, Mathias Schäfersküpper4*, Franziska Elisabeth Marquard, M.D.4*, Radwan Massoud, MD, BS5*, Sofia Oechsler6*, Evgeny Klyuchnikov, M.D.3*, Ina Rudolph4*, Silke Heidenreich, MD4*, Christian Niederwieser, M.D.3*, Catherina Lück, M.D.4*, Dietlinde Janson, M.D.4*, Christine Wolschke, M.D.4*, Boris Fehse, PhD4*, Francis A. Ayuk, M.D.4* and Nicolaus Kroeger, M.D.4

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, AL, Germany
2SC Ematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
3Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
4Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Hamburg, Germany
6University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Eva Rettinger, MD1*, Martin Hutter1*, Birte Karschen2*, Evangelia Antoniou, MD3, Peter Bader, MD1, Rita Beier, MD4*, Birgit Burkhardt, MD, PhD5, Ursula Creutzig4*, Gabriele Escherich6*, Jan-Henning Klusmann, MD7, Peter Lang, MD8*, Naghmeh Niktoreh, MD2*, Martin G. Sauer, MD4, Stephanie Sendker, MD3*, Dirk Reinhardt, MD2 and Katharina Waack9*

1Department of Pediatrics, Goethe University Frankfurt, Frankfurt, Germany
2University Medicine Essen, University Children’s Hospital III, AML BFM Study Group, Essen, Germany
3University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
4Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
5University Hospital Muenster, Department of Paediatric Hematology, Oncology and BMT and NHL-BFM study center, Münster, Germany
6Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
7Department of Pediatrics, Goethe University Frankfurt, Frankfurt, Hessen, Germany
8Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany
9Pediatric Research Network, AML BFM Study Group, Essen, Germany

Kate Stringaris, MB BS, BSc, PhD, MRCP, FRCPath*, Michele Robinson, MBChB, MRCOG*, Melanie C Davies, MA , MRCP, FRCOG*, Anna L David, MB ChB, PhD, FRCOG* and Panagiotis Kottaridis, FRCPath, PhD, MSc*

University College London Hospitals, London, United Kingdom

Thuy T Koll, M.D.1*, Megan Kerns, B.S.1*, Tanya M. Wildes, MD, MSc1, Vijaya Raj Bhatt, MD2, Krishna Gundabolu, MBBS3, Lori Maness, MD4, Michael Haddadin, MBBS4, Marcia Free, BSN1*, Elizabeth R Lyden, PhD5*, Daniel L Murman, M.D.5* and Alfred L Fisher, M.D.6*

1University of Nebraska Medical Center, Omaha, NE
2The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
3Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center College of Medicine, Omaha, NE
4Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
5University of Nebraska Medical Center, Omaha
6University Of Nebraska Medical Center, Omaha, NE

Jonathan Allen Webster, MD1, Madison C Reed, MD2*, Hua-Ling Tsai, Sc.M3*, Philip Imus, MD4, B. Douglas Smith, MD1, Alexander J. Ambinder, MD, MPH1, Mark J. Levis1, Amy E. DeZern, MD, MHS5, Gabrielle T. Prince, MD1*, Javier Bolanos-Meade, MD6*, Lukasz P. Gondek, MD, PhD1, Gabriel Ghiaur, MD, PhD7, William Brian Dalton, MD, PhD1, Theodoros Karantanos, MD, PhD1, Suman Paul, MBBS, PhD8, Ephraim Joseph Fuchs, MD, MBA4, Cole Sterling, MD9, Lode J. Swinnen, MBCHB10, Nina D. Wagner-Johnston, MD11, Richard F. Ambinder, MD12, Christian B. Gocke, MD, PhD13, Syed Abbas Ali1, Carol Ann Huff13*, Leo Luznik, MD14, Ravi Varadhan15*, Richard J. Jones, MD4 and Ivana Gojo, MD1

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
2Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
3Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
4Johns Hopkins University, Baltimore, MD
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
6Johns Hopkins University Kimmel Cancer Center, Ellicott City, MD
7Division of Hematologic Malignancies, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
8Division of Hematologic Malignancies, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD
9Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
10Johns Hopkins Cancer Center, Baltimore, MD
11Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
12Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
13Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
14Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD
15Johns Hopkins, Baltimore, MD

Moazzam Shahzad, MD1,2, Sohaib Irfan, MD2,3*, Muhammad Kashif Amin, MD2,3,4*, Muhammad Jawad Javed, MBBS2,3, Matthew McGuirk2,3*, Sibgha Gull Chaudhary, MD2,3,4*, Iqra Anwar, MBBS2,3*, Zobia Farooq2,3*, Abdulraheem Yacoub, MD2*, Anurag K. Singh, MD2,3,4, Mehdi Hamadani, MD5, Joseph P. McGuirk, DO2,3,4 and Muhammad Umair Mushtaq2,3,4

1Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
2Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
5Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Yu-Han Chen, MD1, Andrea Yue-En Sun2*, Karishma Narain, MD1*, Natasha Rastogi, MD1* and Cho-Hao Lee, MD3*

1Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, NJ
2College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
3Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Taipei, Taiwan

Osama Ahmad1*, Jan Frederic Weller, MD1*, Nicolaus Kröger, MD2*, Eva Wagner Drouet3*, David Nachbaur, M.D.4*, Normann Steiner4*, Daniel Teschner, MD5*, Sabrina Kraus5*, Gesine Bug6*, Salem Ajib6*, Johannes Schetelig, MD, MSc7, Wolfgang Andreas Bethge, MD8*, Thomas Schroeder9*, Judith Schaffrath, MD10*, Lutz Peter Hermann Mueller, MD11*, Mareike Verbeek, MD12*, Edgar Jost, MD13*, Hatice Soysal, MD13*, Georg-Nikolaus Franke, MD14*, Stefan Klein, MD15, Udo Holtick16*, Knut Wendelin17*, Claudia Lengerke, MD18, Martin Bornhäuser, MD7* and Maximilian Christopeit1,19*

1Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
2University Medical Center Hamburg, Hamburg, Germany
3Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany
4University Hospital of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
5Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, Würzburg, Germany
6Dept. of Medicine 2, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
7Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
8Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
9Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Essen, Germany
10Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany
11Department of Internal Medicine IV, University Hospital Halle Martin Luther, University Halle-Wittenberg, Halle, Germany
12Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
13Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Medical Faculty, Aachen, Germany
14Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
15Universitätsmedizin Mannheim, Mannheim, Germany
16Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany
17Med Clinic 5, Klinikum Nürnberg, Nuernberg, Germany
18Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
19University Cancer Center Hamburg, Department of Medicine II - Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hamburg, Germany

Qamar Iqbal, MD1*, Sohaib Irfan, MD2*, Ahmad Basharat3*, Prashil Dave, MBBS4, Ahmed Hebishy, MBBCh5, Muhammad Kashif Amin, MD6*, Muhammad Umair Mushtaq7 and Moazzam Shahzad, MD8

1Hospitalist, TidalHealth, Salisbury, MD
2Aga Khan University, Karachi, Pakistan
3Marshfield Clinic Health System, Marshfield, Wisconsin, Marshfield, WI
4SUNY Downstate Health Sciences University, Brooklyn, NY
5East Carolina University/Brody School of Medicine, Greenville, NC
6Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
7Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
8H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Moazzam Shahzad, MD1,2, Zouina Sarfraz, MBBS1,3*, Ben Ponvilawan, MD1,3*, Muhammad Kashif Amin, MD1,3,4*, Ankita Gupta, MD1,3*, Matthew McGuirk1,3*, Sibgha Gull Chaudhary, MD1,3,4*, Iqra Anwar, MBBS1,3*, Leyla O. Shune, MD1,4,5, Joseph P. McGuirk, DO1,3,4, Mehdi Hamadani, MD6 and Muhammad Umair Mushtaq1,3,4

1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
2Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
5University of Kansas Medical Center, Kansas City, KS
6Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Thi Thuy Duong Pham, BS1,2,3*, Su-Young Choi, BS1,2,3*, Buyeon Heo, BS1,2,3*, Sang-Woo Lee1*, Myung-Won Lee, MD4, Jung-Hyun Park, PhD5*, Yunseon Jang, PhD5*, Deog-Yeon Jo, MD, PhD4, Jaeyul Kwon, PhD1,2,3,5*, Ik Chan Song, MD, PhD1,3,4,5 and Jeong Suk Koh6*

1Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
2Department of Infection Biology, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
3Brain Korea 21 FOUR Project for Medical Science, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
4Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
5Translational Immunology Institute, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
6Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, FL, South Korea

*signifies non-member of ASH